Back to SRS Investment Management, LLC SRS Investment Management, LLC

TXGTXG

Showing 1 of 13 quarters

Position history for SRS Investment Management, LLCSRS Investment Management, LLC's holdings in 10x Genomics, Inc.

No. SRS Investment Management exited its TXG (10x Genomics) position in Q3 2024. Its Q2 2024 13F listed 504,257 shares worth $9.8M. SRS Investment Management first reported TXG in Q3 2021 and held it in 11 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

$0

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q3
Latest
Exited
0
-100.0%
$00.0%$22.67
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used